List of Publications

 

Publications
International collaborative papers (peer reviewed)
  1. Cui Y, Ren S, Tha KK, Wu J, Shirato H, Li R,Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma, European Radiology, 1-10, (2017) [Overseas journal]
  2. Wu J, Sun X, Wang J, Cui Y, Kato F, Shirato H, Ikeda DM, Li R,Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validation, Journal of Magnetic Resonance Imaging, , (2017) [Overseas journal]
  3. Kon S, Ishibashi K, Katoh H, Kitamoto S, Kajita M, Ishikawa S, Yamauchi H, Yako Y, Kamasaki T, Matsumoto T, Watanabe H, Egami R, Sasaki A, Nishikawa A, Kameda I, Maruyama T, Sasaki Y, Enoki R, Honma S, Imamura H, Oshima M, Soga T, Miyazaki J, Sato T, Duchen M, Shirai T, Tanaka S, Narumi R, Morita T, Nam JM, Onodera Y, Yoshioka S, Kikuta J, Ishii M, Imajo M, Nishida E, Fujioka Y, Ohba Y, Fujita Y,Cell competition with normal epithelial cells promotes apical extrusion of transformed cells through metabolic changes, Nature Cell Biology, in press, (2017) [Overseas journal]
  4. Fujima N, Sakashita T, Homma A, Shimizu Y, Yoshida A, Harada T, Tha KK, Kudo K, Shirato H,Advanced diffusion models in head and neck squamous cell carcinoma patients: Goodness of fit, relationships among diffusion parameters and comparison with dynamic contrast-enhanced perfusion, Magnetic resonance imaging, 36, 16-23, (2017) [Overseas journal]
  5. Soyama T, Sakuhara Y, Kudo K, Abo D, Wang J, Ito YM, Hasegawa Y, Shirato H,Comparison of conventional ultrasonography and ultrasonography-computed tomography fusion imaging for target identification using digital/real hybrid phantoms: a preliminary study, Journal of Medical Ultrasonics, 43(3), 327-335, (2016) [Japanese journal]
  6. Kudo K, Uwano I, Hirai T, Murakami R, Nakamura H, Fujima N, Yamashita F, Goodwin J, Higuchi S, Sasaki M.,Comparison of Different Post-Processing Algorithms for Dynamic Susceptibility Contrast Perfusion Imaging of Cerebral Gliomas, Magnetic Resonance in Medical Sciences, mp-2016, (2016) [Japanese journal]
  7. Mimura R, Kato F, Tha KK, Kudo K, Konno Y, Oyama-Manabe N, Kato T, Watari H, Sakuragi N, Shirato H, Comparison between borderline ovarian tumors and carcinomas using semi-automated histogram analysis of diffusion-weighted imaging: focusing on solid components, Japanese journal of radiology, 34(3), 229-237, (2016) [Japanese journal]
  8. Kwon J, Sutherland K, Hashimoto T, Shirato H, Date H,Spatial distributions of dose enhancement around a gold nanoparticle at several depths of proton Bragg peak., Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, 384, 113-120, (2016) [Overseas journal]
  9. Hamaguchi H, Tha KK, Sugimori H, Nakanishi M, Nakagawa S, Fujiwara T, Yoshida H, Takamori S, Shirato H,Effect of respiratory and cardiac gating on the major diffusion-imaging metrics, The neuroradiology journal, 29(4), 254-259, (2016) [Overseas journal]
  10. Fujima N, Yoshida D, Sakashita T, Homma A, Tsukahara A, Shimizu Y, Tha KK, Kudo K, Shirato H,Prediction of the treatment outcome using intravoxel incoherent motion and diffusional kurtosis imaging in nasal or sinonasal squamous cell carcinoma patients, European radiology, 1-10, (2016) [Overseas journal]
  11. Kudo K, Liu T, Murakami T, Goodwin J, Uwano I, Yamashita F, Higuchi S, Wang Y, Ogasawara K, Ogawa A, Sasaki M,Oxygen Extraction Fraction Measurement using Quantitative Susceptibility Mapping: Comparison with Positron Emission Tomography, Journal of Cerebral Blood Flow & Metabolism, 36(8), 1424-1433, (2016) [Overseas journal]
  12. Wang J, Kato F, Yamashita H, Baba M, Cui Y, Li R, Oyama-Manabe N, Shirato H,Automatic Estimation of Volumetric Breast Density Using Artificial Neural Network-Based Calibration of Full-Field Digital Mammography: Feasibility on Japanese Women With and Without Breast Cancer., Journal of digital imaging, 1-13, (2016) [Overseas journal]
  13. Maeda K, Yasui H, Matsuura T, Yamamori T, Suzuki M, Nagane M, Nam JM, Inanami O, Shirato H,Evaluation of the relative biological effectiveness of spot-scanning proton irradiation in vitro, Journal of radiation research, 57(3):307-11, (2016) [Overseas journal]
  14. Hamada T, Sutherland K, Ishikawa M, Miyamoto N, Honma S, Shirato H, Honma K.,In vivo imaging of clock gene expression in multiple tissues of freely moving mice, Nature communications, 7, (2016) [Overseas journal]
  15. Narita H, Tha KK, Hashimoto N, Hamaguchi H, Nakagawa S, Shirato H,Mean kurtosis alterations of cerebral white matter in patients with schizophrenia revealed by diffusion kurtosis imaging, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 71, 169-175, (2016) [Overseas journal]
  16. Cui Y, Song J, Pollom E, Alagappan M, Shirato H, Chang DT, Koong AC, Li R,Quantitative Analysis of 18F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy, International Journal of Radiation Oncology* Biology* Physics, 96(1), 102-109, (2016) [Overseas journal]
  17. Hashimoto A, Oikawa T, Hashimoto S, Sugino H, Yoshikawa A, Otsuka Y, Handa H, Onodera Y, Nam JM, Oneyama C, Okada M, Fukuda M, Sabe H,P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance, J Cell Biol, jcb-201510002, (2016) [Overseas journal]
  18. Komiya Y, Onodera Y, Kuroiwa M, Nomimura S, Kubo Y, Nam JM, Kajiwara K, Nada S, Oneyama C, Sabe H, Okada M,The Rho guanine nucleotide exchange factor ARHGEF5 promotes tumor malignancy via epithelial-mesenchymal transition., Oncogenesi, 5(9), e258, (2016) [Overseas journal]
  19. Otsuka Y, Sato H, Oikawa T, Onodera Y, Nam JM, Fukunaga K, Hatanaka KC, Hatanaka Y, Matsuno Y, Fukuda S, Sabe H,High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue, Cell Communication and Signaling, 14(1), 28, (2016) [Overseas journal]
  20. Rankin EB, Nam JM, Giaccia AJ,Hypoxia: Signaling the Metastatic Cascade, Trends in Cancer, 2(6), 295-304, (2016) [Overseas journal]
  21. Morioka Y, Nam JM, Ohashi T,Nik-related kinase regulates trophoblast proliferation and placental development by modulating AKT phosphorylation, PloS one, 12(2), e0171503, (2016) [Overseas journal]
  22. Kazumata K, Tha KK, Narita H, Shichinohe H, Ito M, Uchino H, Abumiya T.,Investigating Brain Network Characteristics Interrupted by Covert White Matter Injury in Patients with Moyamoya Disease: Insights from Graph Theoretical Analysis, World neurosurgery, 89, 654-665, (2016) [Overseas journal]
  23. Bennink E, Oosterbroek J, Kudo K, Viergever MA, Velthuis BK, de Jong HW,Fast nonlinear regression method for CT brain perfusion analysis, Journal of Medical Imaging, 3(2), 026003-026003, (2016) [Overseas journal]
  24. Tan C, Shichinohe H, Wang Z, Hamauchi S, Abumiya T, Nakayama N, Kazumata K, Ito T, Kudo K, Takamoto S, Houkin K,Feasibility and efficiency of human bone marrow stromal cell culture with allogeneic platelet lysate-supplementation for cell therapy against stroke, Stem Cells International, , (2016) [Overseas journal]
  25. Kazumata K, Tha KK, Narita H, Ito YM, Shichinohe H, Ito M, Uchino H, Abumiya T,Characteristics of Diffusional Kurtosis in Chronic Ischemia of Adult Moyamoya Disease: Comparing Diffusional Kurtosis and Diffusion Tensor Imaging, American Journal of Neuroradiology, 37(8), 1432-1439, (2016) [Overseas journal]
  26. Kazumata K, Tha KK, Uchino H, Shiga T, Shichinohe H, Ito M, Nakayama N, Abumiya T,Topographic changes in cerebral blood flow and reduced white matter integrity in the first 2 weeks following revascularization surgery in adult moyamoya disease, Journal of Neurosurgery, 1-10, (2016) [Overseas journal]
  27. Roseman DA, Hwang SJ, Oyama-Manabe N, Chuang ML, O’Donnell CJ, Manning WJ, Fox CS,Clinical associations of total kidney volume: The framingham heart study, Nephrology Dialysis Transplantation, gfw237, (2016) [Overseas journal]
  28. Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, Leung E, Wells GA, Yoshinaga K, Tsujino I, Sato T, Manabe O, Oyama-Manabe N, Nishimura M, Tamaki N, Dick A, Dennie C, Klein R, Renaud J, deKemp RA, Ruddy TD, Chow BJ, Davies R, Hessian R, Liu P, Beanlands RS, Nery PB,Comparison of (18)f-fluorodeoxyglucose positron emission tomography (fdg pet) and cardiac magnetic resonance (cmr) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis. European journal of nuclear medicine and molecular imaging, European journal of nuclear medicine and molecular imaging, 43(2), 259-269, (2016) [Overseas journal]
  29. Uchino H, Kim JH, Fujima N, Kazumata K, Ito M, Nakayama N, Kuroda S, Houkin K,Synergistic Interactions Between Direct and Indirect Bypasses in Combined Procedures: The Significance of Indirect Bypasses in Moyamoya Disease, Neurosurgery, , (2016) [Overseas journal]
  30. Matsuura T, Fujii Y, Takao S, Yamada T, Matsuzaki Y, Miyamoto N, Takayanagi T, Fujitaka S, Shimizu S, Shirato H: “Development and evaluation of a short-range  applicator for treating superficial moving tumors with respiratory-gated spot-scanning proton therapy using real-time image guidance.”, Phys Med Biol., 61(4):1515-31 (2016) [Overseas journal]*i)
  31. Takao S, Miyamoto N, Matsuura T, Onimaru R, Katoh N, Inoue T, Sutherland KL, Suzuki R, Shirato H, Shimizu S: “Intrafractional Baseline Shift or Drift of Lung Tumor Motion During Gated Radiation Therapy With a Real-Time Tumor-Tracking System.”, Int J Radiat Oncol Biol Phys., 94(1):172-80 (2016) [Overseas journal]*i)
  32. Harada K, Katoh N, Suzuki R, Ito YM, Shimizu S, Onimaru R, Inoue T, Miyamoto N, Shirato H. “Evaluation of the motion of lung tumors during stereotactic body radiation therapy (SBRT) with four-dimensional computed tomography (4DCT) using real-time tumor-tracking radiotherapy system (RTRT).”,Phys Med., 32(2):305-11. (2016) [Overseas journal]*i)
  33. Hashimoto A, Oikawa T, Hashimoto S, Sugino H, Yoshikawa A, Otsuka Y, Handa H, Onodera Y, Nam JM, Oneyama C, Okada M, Fukuda M, Sabe H.: “P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.”, J Cell Biol., in press (2016) [Overseas journal]*i)
  34. Fujima N, Osanai T, Shimizu Y, Yoshida A, Harada T, Nakayama N, Kudo K, Houkin K, Shirato H: “Utility of noncontrast-enhanced time-resolved four-dimensional MR angiography with a vessel-selective technique for intracranial arteriovenous malformations.” , J Magn Reson Imaging., in press (2016) [Overseas journal]*i)
  35. Fujima N, Yoshida D, Sakashita T, Homma A, Tsukahara A, Tha KK, Kudo K, Shirato H: “Usefulness of Pseudocontinuous Arterial Spin-Labeling for the Assessment of Patients with Head and Neck Squamous Cell Carcinoma by Measuring Tumor Blood Flow in the Pretreatment and Early Treatment Period.”, AJNR Am J Neuroradiol., Feb;37(2):342-8, (2016) [Overseas journal]*i)
  36. Maeda K, Yasui H, Matsuura T, Yamamori T, Suzuki M, Nagane M, Nam JM, Inanami O, Shirato H: “Evaluation of the relative biological effectiveness of spot-scanning proton irradiation in vitro.,  Journal of Radiation Research.”, in press, (2016) [Overseas journal]*i)
  37. Kato F, Kudo K, Yamashita H, Wang J, Hosoda M, Hatanaka KC, Mimura R, Oyama-Manabe N, Shirato H: “Differences in morphological features and minimum apparent diffusion coefficient values among breast cancer subtypes using 3-tesla MRI.”, Eur J Radiol., 85(1):96-102. (2016) [Overseas journal]
  38. Wang J, Kato F, Oyama-Manabe N, Li R, Cui Y, Tha KK, Yamashita H, Kudo K, Shirato H: “Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study.”, PLoS One., 10(11):e0143308. (2015) [Overseas journal]*i)
  39. Sugano Y, Mizuta M, Takao S, Shirato H, Sutherland KL, Date H: “Optimization of the fractionated irradiation scheme considering physical doses to tumor and organ at risk based on dose-volume histograms.”, Med Phys., 42;11:6203-6210 (2015) [Overseas journal]
  40. Onimaru R, Hida K, Takeda N, Onodera S, Nishikawa Y, Mori T, Shirato H: “Three-dimensional conformal fractionated radiotherapy for spinal schwannoma with a paravertebral or an intraosseous component.”, Jpn J Radiol., 33(12):757-63, (2015) [Overseas journal]
  41. Cui Y, Tha KK, Terasaka S, Yamaguchi S, Wang J, Kudo K, Xing L, Shirato H, Li R: “Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images.”, Radiology., 278(2):546-53, (2015) [Overseas journal]*i) ii)
  42. Harada Y, Hirata K, Nakayama N, Yamaguchi S, Yoshida M, Onodera S, Manabe O, Shiga T, Terae S, Shirato H, Tamaki N: “Improvement of cerebral hypometabolism after resection of radiation-induced necrotic lesion in a patient with cerebral arteriovenous malformation.”, Acta Radiol Open., 27;4(6):2058460115584112, (2015) [Overseas journal]
  43. Fujima N, Kameda H, Tsukahara A, Yoshida D, Sakashita T, Homma A, Tha KK, Kudo K, Shirato H: “Diagnostic value of tumor blood flow and its histogram analysis obtained with pCASL to differentiate sinonasal malignant lymphoma from squamous cell carcinoma.”, Eur J Radiol., 84(11):2187-93, (2015) [Overseas journal]*i)
  44. Onimaru R, Shirato H, Shibata T, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Onishi H: “Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100cc using a continual reassessment method (JCOG0702).”, Radiother Oncol., 116(2):276-80, (2015) [Overseas journal]
  45. Aoyama H, Tago M, Shirato H: Japanese Radiation Oncology Study Group 99-1 (JROSG 99-1) Investigators: “Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.”, JAMA Oncol., 1(4):457-64, (2015) [Overseas journal]
  46. Le QT, Shirato H, Giaccia AJ, Koong AC: Emerging Treatment Paradigms in Radiation Oncology., Clin Cancer Res., 1;21(15):3393-401, (2015) [Overseas journal]*i) ii)
  47. Kunimatsu J, Miyamoto N, Ishikawa M, Shirato H, Tanaka M: “Application of radiosurgical techniques to produce a primate model of brain lesions.”, Front Syst Neurosci., 24;9:67. (2015) [Overseas journal]
  48. Furusawa J, Homma A, Onimaru R, Sakashita T, Yoshida D, Hatakeyama H, Mizumachi T, Kano S, Tsuchiya K, Yasuda K, Shirato H, Fukuda S: “Indications for superselective intra-arterial cisplatin infusion and concomitant radiotherapy in cases of hypopharyngeal cancer.”, Auris Nasus Larynx., 42(6):443-8, (2015) [Overseas journal]
  49. Homma A, Nakamaru Y, Sakashita T, Onimaru R, Terasaka S, Tsuchiya K, Yoshida D, Yasuda K, Hatakeyama H, Furusawa J, Mizumachi T, Kano S, Shirato H, Fukuda S: “Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: A single institution experience”, Auris Nasus Larynx., 42(5):377-81 (2015) [Overseas journal]
  50. Sakuhara Y, Nishio S, Morita K, Abo D, Hasegawa Y, Yuasa N, Mochizuki T, Soyama T, Oba K, Shirato H, Kudo K: “Transcatheter Arterial Embolization with Ethanol Injection in Symptomatic Patients with Enlarged Polycystic Kidneys.”, Radiology., 277(1):277-85, (2015) [Overseas journal]
  51. Mori T, Onimaru R, Onodera S, Tsuchiya K, Yasuda K, Hatakeyama H, Kobayashi H, Terasaka S, Homma A, Shirato H: “Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.”, Radiat Oncol., 15;10(1):88. (2015) [Overseas journal]
  52. Sakashita T, Homma A, Hatakeyama H, Furusawa J, Kano S, Mizumachi T, Iizuka S, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Fukuda S: “Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.”, Acta Otolaryngol., 135(8):853-8. (2015) [Overseas journal]
  53. Sakashita T, Homma A, Hatakeyama H, Furusawa J, Kano S, Mizumachi T, Iizuka S, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Fukuda S: “Clinical outcomes of weekly cisplatin chemoradiotherapy for patients with pyriform sinus cancer.”, Int J Clin Oncol., 20(6):1081-5. (2015) [Overseas journal]
  54. Fujima N, Kudo K, Tsukahara A, Yoshida D, Sakashita T, Homma A, Tha KK, Shirato H: “Measurement of tumor blood flow in head and neck squamous cell carcinoma by pseudo-continuous arterial spin labeling: comparison with dynamic contrast-enhanced MRI.”, J Magn Reson Imaging., 41(4):983-91, (2015) [Overseas journal]
  55. Homma A, Nakamaru Y, Sakashita T, Onimaru R, Terasaka S, Tsuchiya K, Yoshida D, Yasuda K, Hatakeyama H, Furusawa J, Mizumachi T, Kano S, Shirato H, Fukuda S: Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: A single institution experience., Auris Nasus Larynx. 42(5):377-81, (2015) [Overseas journal]
  56. Ishihara S, Yasuda M, Ishizu A, Ishikawa M, Shirato H, Haga H: “Activating transcription factor 5 nhances radioresistance and malignancy in cancer cells.”, Oncotarget., 10;6(7):4602-14 (2015) [Overseas journal]
  57. Bazalova-Carter M, Ahmad M, Matsuura T, Takao S, Matsuo Y, Fahrig R, Shirato H, Umegaki K, Xing L: “Proton-induced x-ray fluorescence CT imaging.”, Med Phys., 2015 Feb;42(2):900-7 (2015) [Overseas journal]*i)
  58. Ishikawa M, Nagase N, Matsuura T, Hiratsuka J, Suzuki R, Miyamoto N, Sutherland KL, Fujita K, Shirato H: “Development of a wavelength-separated type scintillator with optical fiber (SOF) dosimeter to compensate for the Cerenkov radiation effect.”, J Radiat Res., 56(2):372-81. (2015) [Overseas journal]
  59. Miyamoto N, Yabusaki S, Sakamoto K, Kikuchi Y, Mimura R, Kato F, Oyama-Manabe N, Takahashi B, Soyama T, Abo D, Sakuhara Y, Kudo K, Shirato H, Nakamura T, Tsuchikawa T, Okamura K, Hirano S: “Prediction of pancreatic anastomotic failure after pancreatic head resection using preoperative diffusion-weighted MR imaging.”, Jpn J Radiol., 33: 59-66 (2015) [Overseas journal]
  60. Yamaguchi S, Hirata K, Kaneko S, Kobayashi H, Shiga T, Kobayashi K, Onimaru R, Shirato H, Tamaki N, Terasaka S, Houkin K: “Combined use of 18 F-FDG PET and corticosteroid for diagnosis of deep-seated primary central nervous system lymphoma without histopathological confirmation”, Acta Neurochir (Wien), 157(2):187-94 (2015) [Overseas journal]
  61. Miyamoto N, Ishikawa M, Sutherland K, Suzuki R, Matsuura T, Toramatsu C, Takao S, Nihongi H, Shimizu S, Umegaki K, Shirato H: “A motion-compensated image filter for low-dose fluoroscopy in a real-time tumor-tracking radiotherapy system.”, J Rad Res., 56(1):186-196, (2015) [Overseas journal]
  62. Mizumachi T, Homma A, Kakizaki T, Sakashita T, Kano S, Hatakeyama H, Tsuchiya K, Yasuda K, Onimaru R, Shirato H, Taguchi J, Shimizu Y, Kinoshita I, Akita H, Fukuda S: “Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma”, Int J Clin Oncol., 20(3):431-7 (2015) [Overseas journal]
  63. Ishizaka K, Kato F, Terae S, Mito S, Oyama-Manabe N, Kamishima T, Nakanishi M, Sugimori H, Hamaguchi H, Shirato H: “Bilateral breast MRI by use of dual-source parallel radiofrequency excitation and image-based shimming at 3 Tesla: improvement in homogeneity on fat-suppression imaging.”, Radiol Phys Technol., 8(1):4-12 (2015) [Overseas journal]
  64. Kato F, Oyama-Manabe N, Sakuhara Y, Mito S, Takahashi M, Sakamoto T, Hosoda M, Terae S, Shirato H: “Earlier and better high-resolution single breast imaging during bilateral breast dynamic scans at 3-T MRI: comparison with post dynamic high-resolution imaging.”, Breast Cancer., 22;5:475-479 (2015) [Overseas journal]
  65. Hirata Y, Miyamoto N, Shimizu M, Yoshida M, Hiramoto K, Ichikawa Y, Kaneko S, Sasagawa T, Hiraoka M, Shirato H: “International standardization of four dimensional radiotherapy system – Enhancement of effects of irradiation and assurance of safety.”, Synthesiology-English edition, 7(4): 229-238 (2015) [Overseas journal]*ii)
  66. Watanabe S, Okamoto S, Shiga T, Inoue T, Hirata K, Magota K, Nishijima K, Kuge Y, Shirato H, Tamaki N: “Respiratory-gated FMISO-PET CT for the quantitative evaluation of hypoxia in non-small cell lung cancer.”, J Nucl Med, 127(56):3 (2015) [Overseas journal]
  67. Watanabe S, Okamoto S, Shiga T, Inoue T, Hirata K, Magota K, Nishijima K, Kuge Y, Shirato H, Tamaki N: “Respiratory-gated FMISO-PET/CT detects tumor hypoxia with higher sensitivity in non-small cell lung cancer.”, Eur J Nucl Med Mol Imaging., OP144;42:S61-S61 (2015) [Overseas journal]
  68. Fujima N, Nakamaru Y, Sakashita T, Homma A, Tsukahara A, Kudo K, Shirato H: “Differentiation of squamous cell carcinoma and inverted papilloma using non-invasive MR perfusion imaging, Dentomaxillofac Radiol.”, 44(9):20150074. (2015) [Overseas journal]*i)
  69. Kudo K, Liu T, Murakami T, Goodwin J, Uwano I, Yamashita F, Higuchi S, Wang Y, Ogasawara K, Ogawa A, Sasaki M: “Oxygen Extraction Fraction Measurement using Quantitative Susceptibility Mapping: Comparison with Positron Emission Tomography.”, JCBFM, in press (2015) [Overseas journal]
  70. Harada T, Abe T, Kato F, Matsumoto R, Fujita H, Murai S, Miyajima N, Tsuchiya K, Maruyama S, Kudo K, Shinohara N: “Five-point Likert scaling on MRI predicts clinically significant prostate carcinoma.”, BMC Urol., 4;15:91, (2015) [Overseas journal]
  71. Homma A, Sakashita T, Hatakeyama H, Kano S, Mizumachi T, Nakamaru Y, Yoshida D, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Fukuda S: “The efficacy of superselective intra-arterial infusion with concomitant radiotherapy for adenoid cystic carcinoma of the head and neck.”, Acta Otolaryngol., 135(9):950-4, (2015) [Overseas journal]
  72. Shibasaki S, Takahashi N, Homma S, Nishida M, Shimokuni T, Yoshida T, Kawamura H, Oyama-Manabe N, Kudo K, Taketomi A: “Use of transabdominal ultrasonography to preoperatively determine T-stage of proven colon cancers.”, Abdom Imaging., 40(6):1441-50, (2015) [Overseas journal]
  73. Manabe O, Hattori N, Yamaguchi S, Hirata K, Kobayashi K, Terasaka S, Kobayashi H, Motegi H, Shiga T, Magota K, Oyama-Manabe N, Nishijima K, Kuge Y, Tamaki N: “Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging.”, Eur J Nucl Med Mol Imaging., 42, 896-904, (2015) [Overseas journal]
  74. Mori Y, Manabe O, Naya M, Tomiyama Y, Yoshinaga K, Magota K, Oyama-Manabe N, Hirata K, Tsutsui H, Tamaki N, Katoh C: “Improved spillover correction model to quantify myocardial blood flow by 11C-acetate PET: comparison with 15O-H 2O PET.”, Ann Nucl Med., 29(1):15-20, (2015) [Overseas journal]
  75. Shimizu S, Nishioka K, Suzuki R, Shinohara N, Maruyama S, Abe T, Kinoshita R, Katoh N, Onimaru R, Shirato H: “Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system.”, Radiat Oncol, 21;9(1):118, (2014) [Overseas journal]
  76. Yamaguchi S, Terasaka S, Kobayashi H, Asaoka K, Motegi H, Nishihara H, Kanno H, Onimaru R, Ito YM, Shirato H, Houkin K: “Prognostic factors for survival in patients with high-grade meningioma and recurrence-risk stratification for application of radiotherapy.” PLoS One., 12;9(5):e97108. (2014) [Overseas journal]
  77. Shimizu S, Miyamoto N, Matsuura T, Fujii Y, Umezawa M, Umegaki K, Hiramoto K, Shirato H: “A proton beam therapy system dedicated to spot-scanning increases accuracy with moving tumors by real-time imaging and gating and reduces equipment size.”, PLoS One., 18;9(4) (2014) [Overseas journal]
  78. Shimizu S, Matsuura T, Umezawa M, Hiramoto K, Miyamoto N, Umegaki K, Shirato H: “Preliminary analysis for integration of spot-scanning proton beam therapy and real-time imaging and gating.”, Phys Med., 30(5) 555-558 (2014) [Overseas journal]
  79. Shimizu S, Tsuchiya K, Takao S, Shirato H: “Advanced radiation therapy project for cancer treatment–from Hokkaido to the world, the world access to Hokkaido, Hokkaido Igaku Zasshi”, 89(1):25-8, (2014) [Japanese journal]
  80. Onodera S, Aoyama H, Tha KK, Hashimoto N, Toyomaki A, Terae S, Shirato H: The value of 4-month neurocognitive function as an endpoint in brain metastases trials, J Neurooncol, 120(2):311-319, (2014) [Overseas journal]
  81. Kikuchi Y, Oyama-Manabe N, Naya M, Manabe O, Tomiyama Y, Sasaki T, Katoh C, Kudo K, Tamaki N, Shirato H: “Quantification of myocardial blood flow using dynamic 320-row multi-detector CT as compared with ¹⁵O-H₂O PET.”Eur Radiol. 24(7):1547-56, (2014) [Overseas journal]
  82. Yamazaki R, Onimaru R, Katoh N, Inoue T, Nishioka T, ShiratoH, Date H: “Influence of respiration on dose calculation in stereotactic body radiotherapy of the lung.”, Radiol Phys Technol., 7(2):284-9, (2014) [Overseas journal]
  83. Sakashita T, Homma A, Hatakeyama H, Kano S, Mizumachi T, Furusawa J, Yoshida D, Fujima N, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Suzuki F, Fukuda S: “Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.”, Br J Oral Maxillofac Surg, 52(4):323-8, (2014) [Overseas journal]
  84. Nishio T, Shirato H, Ishikawa M, Miyabe Y, Kito S, Narita Y, Onimaru R, Ishikura S, Ito Y, Hiraoka M: “Design, development of water tank-type lung phantom and dosimetric verification in institutions participating in a phase I study of stereotactic body radiation therapy in patients with T2N0M0 non-small cell lung cancer: Japan Clinical Oncology Group trial (JCOG0702)”.J Radiat Res. 55(3):600-7, (2014) [Overseas journal]
  85. Mahabir R, Tanino M, Elmansuri A, Wang L, Kimura T, Itoh T, Ohba Y, Nishihara H, Shirato H, Tsuda M, Tanaka S: “Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma.”, Neuro Oncol., 16(5):671-85, (2014) [Overseas journal]
  86. Sakashita T, Homma A, Hatakeyama H, Kano S, Mizumachi T, Furusawa J, Yoshida D, Fujima N, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Fukuda S.: “The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation.”, Eur Arch Otorhinolaryngol., 271(10):2767-70. (2014) [Overseas journal]
  87. Hirabayashi K, Kinugawa S, Yokota T, Takada S, Fukushima A, Suga T, Takahashi M, Ono T, Morita N, Omokawa M, Harada K, Oyama-Manabe N, Shirato H, Matsushima S, Okita K, Tsutsui H: “Intramyocellular lipid is increased in the skeletal muscle of patients with dilated cardiomyopathy with lowered exercise capacity.”, Int J Cardiol, 176:1110 (2014) [Overseas journal]
  88. Fujima N, Kudo K, Yoshida D, Homma A, Sakashita T, Tsukahara A, Tha KK, Zaitsu Y, Terae S, Shirato H: “Arterial spin labeling to determine tumor viability in head and neck cancer before and after treatment.”, J Magn Reson Imaging., 40(4):920-8 (2014) [Overseas journal]
  89. Fujima N, Yoshida D, Sakashita T, Homma A, Tsukahara A, Tha KK, Kudo K, Shirato H: “Intravoxel incoherent motion diffusion-weighted imaging in head and neck squamous cell carcinoma: Assessment of perfusion-related parameters compared to dynamic contrast-enhanced MRI.”, Magn Reson Imaging., 32(10):1206-1213, (2014) [Overseas journal]
  90. Kawakami H, Abo D, Kawakubo K, Kuwatani M, Yoshino Y, Kubota Y, Abe Y, Kawahata S, Kubo K, Sakuhara Y, Shirato H, Sakamoto N: “Rendezvous biliary recanalization combining percutaneous and endoscopic techniques using a diathermic dilator for bile duct obstruction.”, Endoscopy, 46 Suppl 1 UCTN:E460-1, (2014) [Overseas journal]
  91. Fatema CN, Zhao S, Zhao Y, Yu W, Nishijima K, Yasuda K, Kitagawa Y, Tamaki N, Kuge Y: “Dual tracer evaluation of dynamic changes in intratumoral hypoxic and proliferative states after radiotherapy of human head and neck cancer xenografts using radiolabeled FMISO and FLT”, BMC Cancer, 14:692 (2014) [Overseas journal]
  92. Matsumoto Y, Matsuura T, Wada M, Egashira Y, Nishio T, Furusawa Y: Enhanced radiobiological effects at the distal end of a clinical proton beam: in vitro study, J Radiat Res. 55(4):816-22 (2014) [Overseas journal]
  93. Knopf A, Nill S, Yohannes I, Graeff C, Dowdell S, Kurz C, Sonke JJ, Biegun AK, Lang S, McClelland J, Champion B, Fast M, Wolfelschneider J, Gianoli C, Rucinski A, Baroni G, Richter C, van de Water S, Grassberger C, Weber D, Poulsen P, Shimizu S, Bert C: “Challenges of radiotherapy: report on the 4D treatment planning workshop 2013.”, Phys Med, 30(7):809-15, (2014) [Overseas journal]
Other original papers

Japanese journals (including those in English)

  1. Harada T, Kudo K, Uwano I, Yamashita F, Kameda H, Matsuda T, Sasaki M, Shirato H,Breath-holding during the Calibration Scan Improves the Reproducibility of Parallel Transmission at 7T for Human Brain, Magnetic Resonance in Medical Sciences, 16(1), 23-31, (2017)
  2. Noguchi A, Kato M, Kono M, Ohmura K, Ohira H, Tsujino I, Oyama-Manabe N, Oku K, Bohgaki T, Horita T, Yasuda S, Nishimura M, Atsumi T,Bi-ventricular interplay in patients with systemic sclerosis-associated pulmonary arterial hypertension: Detection by cardiac magnetic resonance, Modern Rheumatology, 1-8, (2016)
  3. Mizumoto M, Murayama S, Akimoto T, Demizu Y, Fukushima T, Ishida Y, Oshiro Y, Numajiri H, Fuji H, Okumura T, Shirato H, Hideyuki S,Long-term follow-up after proton beam therapy for pediatric tumors: A Japanese national survey, Cancer Science, , (2016)
  4. Umegaki K: “Development of an Innovative Proton Beam Therapy System”, Journal of Industry-Academia-Government Collaboration, 1(12), 4-7, (2016)
  5. Shirato H: “Progress of Radiation Therapy System (Feature article, The leading edge in Cancer Radiation Therapy)”, The Journal of the Japan Medical Association, 144:233-236, (2015)
  6. Oyama-Manabe N: “Myocardial perfusion imaging for evaluating viability with contrast enhanced MRI.”, Japanese Journal of Diagnostic Imaging (Rinsho-gazou), 31,159-166, (2015)
  7. Oyama-Manabe N: “Left atrial myxoma, Adipoma, Metastatic cardiac tumor, Fibroma, Malignant lymphoma, ‘CT/MRI for cardiovascular disease’”, Japanese Journal of Diagnostic Imaging, 35, 944-953, (2015)
  8. Oyama-Manabe N: “Heart CT/MRI update: Cardiac perfusion CT.”, Japanese Journal of Clinical Radiology, 60, 212-222, (2015)
  9. Kudo K: “Basic theory of perfusion imaging.”, NICHIDOKU-IHO 60(2): 6-19, (2015)
  10. Kato F, Fujiwara T, Mimura R, Kudo K, Oyama-Manabe N, Sugimori H, Hosoda M, Yamashita K, Shirato H: “Diffusion weighted imaging with slice selection gradient reversal method using 3-tesla breast MRI”, Japanese Journal of Clinical Radiology, 59: 558-562, (2014)
  11. Umegaki K: “Development of a Real-time Tumor-tracking Proton Beam Therapy System with Molecular Imaging”, Electrical review, 99(6):30-34, (2014)
  12. Shimizu S: “Next generation particle therapy: Integration of a real-time tumor monitoring system into gated proton spot-scanning beam therapy”, New Medicine in Japan, 52-55, (2014)
  13. Kudo K: “Diagnostic imaging guideline for central nerve system”,Japanese Journal of Diagnostic Imaging
  14. Kudo K: “MR perfusion imaging, Recent progress in stroke and cerebrovascular diseases”, Nippon rinsho, 72(5):538-543, (2014)

Overseas journals

  1. Manabe O, Hirata K, Shozo O, Shiga T, Uchiyama Y, Kobayashi K, Watanabe S, Toyonaga T, Kikuchi H, Oyama-Manabe N, Tamaki N,18f-fluoromisonidazole (fmiso) pet may have the potential to detect cardiac sarcoidosis, Journal of nuclear cardiology, 24(1):329-331, (2017)
  2. Kanehira T, Matsuura T, Takao S, Matsuzaki Y, Fujii Y, Fujii T, Ito YM, Miyamoto N, Inoue T, Katoh N, Shimizu S, Umegaki K, Shirato H,Impact of Real-Time Image Gating on Spot Scanning Proton Therapy for Lung Tumors: A Simulation Study, International Journal of Radiation Oncology* Biology* Physics, 97(1), 173-181, (2017)
  3. Katoh N, Soda I, Tamamura H, Takahashi S, Uchinami Y, Ishiyama H, Ota K, Inoue T, Onimaru R, Shibuya K, Hayakawa K, Shirato H,Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system. , Radiation Oncology, 12(1), 3, (2017)
  4. Nishioka K, Shimizu S, Shinohara N, Ito YM, Abe T, Maruyama S, Katoh N, Kinoshita R, Hashimoto T, Miyamoto N, Onimaru R, Shirato H,Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers, Radiation Oncology, 12(1), 44, (2017)
  5. Harada K, Katoh N, Suzuki R, Ito YM, Shimizu S, Onimaru R, Inoue T, Miyamoto N, Shirato H,Evaluation of the motion of lung tumors during stereotactic body radiation therapy (SBRT) with four-dimensional computed tomography (4DCT) using real-time tumor-tracking radiotherapy system (RTRT)., Physica Medica, 32(2), 305-311, (2016)
  6. Yoshimura T, Kinoshita R, Onodera S, Toramatsu C, Suzuki R, Ito YM, Takao S, Matsuura T, Matsuzaki Y, Umegaki K, Shirato H, Shimizu S,NTCP modeling analysis of acute hematologic toxicity in whole pelvic radiation therapy for gynecologic malignancies – A dosimetric comparison of IMRT and spot-scanning proton therapy (SSPT), Physica Medica, 32(9), 1095-1102, (2016)
  7. Uchinami Y, Myojin M, Takahashi H, Harada K, Shimizu S, Hosokawa M,Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa., Radiation Oncology, 11(1), 84, (2016)
  8. Onimaru R, Onishi H, Shibata T, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Shirato H,Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV ≧100 cc., Radiotherapy and Oncology, , (2016)
  9. Fujima N, Osanai T, Shimizu Y, Yoshida A, Harada T, Nakayama N, Kudo K, Houkin K, Shirato H,Utility of noncontrast-enhanced time-resolved four-dimensional MR angiography with a vessel-selective technique for intracranial arteriovenous malformations, Journal of Magnetic Resonance Imaging, 44(4), 834-845, (2016)
  10. Fujima N, Sakashita T, Homma A, Hirata K, Shiga T, Kudo K, Shirato H,Glucose Metabolism and Its Complicated Relationship with Tumor Growth and Perfusion in Head and Neck Squamous Cell Carcinoma, PloS one, 11(11), e0166236, (2016)
  11. Yamada T, Miyamoto N, Matsuura T, Takao S, Fujii Y, Matsuzaki Y, Koyano H, Umezawa M, Nihongi H, Shimizu S, Shirato H, Umegaki K,Optimization and evaluation of multiple gating beam delivery in a synchrotron-based proton beam scanning system using a real-time imaging technique, Physica Medica, 32(7), 932-937, (2016)
  12. Tamura M, Sakurai H, Mizumoto M, Kamizawa S, Murayama S, Yamashita H, Takao S, Suzuki R, Shirato H, Ito YM,Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients., Journal of radiation research, rrw088 1-9, (2016)
  13. Maeda K, Yasui H, Yamamori T, Matsuura T, Takao S, Suzuki M, Matsuda A, Inanami O, Shirato H,A Nucleoside Anticancer Drug, 1-(3-C-Ethynyl-β-D-Ribo- Pentofuranosyl) Cytosine, Induces Depth-Dependent Enhancement of Tumor Cell Death in Spread-Out Bragg Peak (SOBP) of Proton Beam, PloS one, 11(11), e0166848, (2016)
  14. Suzuki T, Sakashita T, Homma A, Hatakeyama H, Kano S, Mizumachi T, Yoshida D, Fujima N, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Suzuki F, Fukuda S,Effectiveness of superselective intra-arterial chemoradiotherapy targeting retropharyngeal lymph node metastasis, European Archives of Oto-Rhino-Laryngology, 273(10), 3331-3336, (2016)
  15. Mizumoto M, Murayama S, Akimoto T, Demizu Y, Fukushima T, Ishida Y, Oshiro Y, Numajiri H, Fuji H, Okumura T, Shirato H, Sakurai H,Proton beam therapy for pediatric malignancies: a retrospective observational multicenter study in Japan, Cancer medicine, 5(7), 1519-1525, (2016)
  16. Okamoto S, Shiga T, Yasuda K, Watanabe S, Hirata K, Nishijima KI, Magota K, Kasai K, Onimaru R, Tuchiya K, Kuge Y, Shirato H, Tamaki N,The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy, European journal of nuclear medicine and molecular imaging, 43(12), 2147-2154, (2016)
  17. Niibe Y, Nishimura T, Inoue T, Karasawa K, Shioyama Y, Jingu K, Shirato H.,Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects, BMC cancer , 16(1), 659, (2016)
  18. Homma A, Hatakeyama H, Mizumachi T, Kano S, Sakashita T, Kuramoto R, Nakamaru Y, Onimaru R, Tsuchiya K, Yoshida D, Yasuda K, Shirato H, Fukuda S.,A Retrospective Study of G-Tube Use in Japanese Patients Treated with Concurrent Chemoradiotherapy for Hypopharyngeal Cancer, PloS one, 11(8), e0161734, (2016)
  19. Watanabe S, Manabe O, Hirata K, Oyama-Manabe N, Hattori N, Kikuchi Y, Kobayashi K, Toyonaga T, Tamaki N,The usefulness of (18)f-fdg pet/ct for assessing methotrexate-associated lymphoproliferative disorder (mtx-lpd), BMC cancer, 16(1), 635, (2016)
  20. Sugaya T, Oyama-Manabe N, Yamaguchi T, Tamaki N, Ishimaru S, Okabayashi H, Furuya J, Yoshida T, Igarashi Y, Igarashi K,Visualization of collateral channels with coronary computed tomography angiography for the retrograde approach in percutaneous coronary intervention for chronic total occlusion. Journal of cardiovascular computed tomography, Journal of cardiovascular computed tomography, 10(2), 128-134, (2016)
  21. Manabe O, Oyama-Manabe N, Naya M, Aikawa T, Sakakibara M, Tsutsui H, Tamaki N,Pitfalls of 18f-fdg pet for evaluating myocardial viability, Journal of nuclear cardiology, 1-4, (2016)
  22. Aikawa T, Naya M, Oyama-Manabe N, Maekawa S, Nambu H, Mitsuyama H, Hirata K, Kanno-Okada H, Tsutsui H,18f-fdg pet findings of pericardial lymphangiohemangioma, Journal of nuclear cardiology, 1-3, (2016)
  23. Kubo K, Kawakami H, Kuwatani M, Nishida M, Kawakubo K, Kawahata S, Taya Y, Kubota Y, Amano T, Shirato H, Sakamoto N,Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice: a prospective cohort studya prospective cohort study, BMC gastroenterology, 16(1), 65, (2016)
  24. Shirato H: “Radiotherapy: characteristics of particle therapy and its perspective”, Annals of Oncology, 2015 Nov EL19;26:65-65 (2015)
  25. Tha KK: The directional metrics of diffusion. J Radiol Radiat Ther, 2(2): 1030. (2014)

Published books

  1. Shirato H, Taguchi H:“Radiation Therapy”, Basics and Clinical, Gstroenterology, Nishimurasyoten, Inc., 1341-1344, 2015

 

Presentations
Verbal presentations

Keynote speeches

  1. Shirato H: “Quality of Radiotherapy; Treatment (Quality control, guidelines, standard treatment)”, Yokohama, The 74th Annual Meeting of the Japan Radiological Society, 2015.4.19 [Japanese conference]
  2. Shirato H: “Features and perspectives of radiation therapy and particle therapy”, Sapporo, The 13th Japanese Society of Medical Oncology 2015 Annual Meeting, 2015.7.17 [Japanese conference]
  3. Shirato H: “Present and future of proton beam therapy”, Sapporo, The 9th Specialist Seminar, Hokkaido Branch of the Japanese Society of Gastroenterology Japanese Gastroenterological Endoscopy Society, 2015.8.30 [Japanese conference]
  4. Umegaki K: “Development of gated spot scanning proton beam therapy system with real-time tumor tracking.”, Busan (South Korea) BEXCO, The 7th Korea-Japan Joint Meeting on Medical Physics, Plenary Symposium, 2014.9.25 [International conference]

Invited lectures

  1. Shirato H. Painful years for particle beam therapists resulted in a little hope: Japanese experience, The 5th Japan-Taiwan Radiation Oncology Symposium ” No Pain, No Gain”, 2017.5.20, Kobe, Japan [International conference]
  2. Kudo K Radiomics is Radio-MIX, Mix everything! 5th ICMRI Souel, Korea 2017.3.23 2017.3.25 [International conference]
  3. Kudo K SWI and QSM in Stroke and Misery Perfusion, 5th ICMRI Souel, Korea 2017.3.23 2017.3.25 [International conference]
  4. Shirato H. “Real-time Tumour Tracking. Sharing the Vision for World Class Radiotherapy”, Manchester, 2017.3.20. [International conference]
  5. Shirato H. “Real-time-image gated proton beam therapy (RGPT).” The 21st Annual Fall Symposium of Korean Cancer Association, Seoul, 2016.11.18. [International conference]
  6. Kudo K Academic and Social Member Management, 2nd AOSOR Chiang Mai, Thailand 2016.11.17 2016.11.19 [International conference]
  7. Shimizu S: “Particle therapy – scanning method and gating for motion management.”, The 3rd GI-CoRE Medical Science and Engineering Symposium. Radiation Oncology, Biology&IVR, Sapporo, 2016.3.4 [International conference]
  8. Nam JM: “Targeting integrin signaling to improve the efficacy of radiation treatment on breast cancer cells.”, The 3rd GI-CoRE Medical Science and Engineering Symposium. Radiation Oncology, Biology&IVR, Sapporo, 2016.3.3 [International conference]
  9. Shimizu S: Radiation therapy and particle therapy among the options for cancer treatment, The 30th Sapporo Winter Cancer Seminar, Sapporo Cancer Seminar Foundation, 2016.1.30 [Japanese conference]
  10. Shirato H: “New directions in particle beam therapy – From therapeutic science to health care medicine”, Maehashi, The 28th Annual Meeting of the Japanese Society for Radiation Oncology, 2015.11.20 [Japanese conference]
  11. Umegaki K: “Development of the innovative proton beam therapy system through industry-academia collaboration”, Tokyo Medical and Dental University, medU-net Regulatory Science Seminar, 2015.11.12 [Japanese conference]
  12. Shimizu S: “Real time image-gated proton beam therapy.”, Seoul (South Korea), The 14th Seoul Radiation Oncology Symposium: Updates in Image-Guided Radiation Therapy, 2015.10.30 [International conference]
  13. Kudo K: Contrast Enhanced MRI for Brain Tumors, 10th AOCNR Fukuoka, Japan 2015.11.5 [International conference]
  14. Tha KK: Identification of Noninvasive Biomarkers for Glioblastoma: The Role of “Radiomics”. Taipei (Taiwan), NeuroImaging Summit., 2015.10.17 [International conference]
  15. Shimizu S: “Mission of the innovative proton beam therapy system”, Hakodate, The 52nd Annual Congress of Japan Municipal Hospital Association, 2015.10.9 [Japanese conference]
  16. Umegaki K, Shirato H: “Development of Real-time Image Gated Spot Scanning Proton Beam Therapy (RGPT) system, National Taiwan University”, 2015 International Symposium on Radiation Medicine 2015.10.4 [International conference]
  17. Shimizu S: “The latest proton beam therapy system”, Morioka, Iwate Prefectural Information Exchange Center, From photon beam therapy to particle beam therapy, The 51st Autumn Assembly of the Japan Radiological Society, 2015.10.3 [Japanese conference]
  18. Umegaki K: “Proton beam therapy system using a real-time tumor monitoring system and spot-scanning beam therapy – From development to clinical application”, Hokkaido University, The 110th Annual Meeting of the Japan Society of Medical Physics, Sapporo, 110th Japan Society of Medical Physics, 2015.9.20 [Japanese conference]
  19. Shimizu S: “Callenge of the Global Station for Quantum Medical Science and Engineering.”, Sapporo, 110th Japan Society of Medical Physics, 2015.9.19 [Japanese conference]
  20. Shimizu S: “Proton beam therapy.”, Patient Adovocate Program (PAP), Sapporo, The 13th Japanese Society of Medical Oncology 2015 Annual Meeting, 2015.7.17 [Japanese conference]
  21. Tha KK: Current Aspects of Radiomics in Neuroimaging: The 44th Annual Meeting of Japan Society for Magnetic Resonance in Medicine, KSMRM-JSMRM Joint Symposium Session, Omiya, Japan, 2014 [Japanese conference]
  22. Tha KK: Tumors and the cerebral white matter: The 14th Annual Meeting of Myanmar Radiological Society, Yangon, Myanmar,2014 [International conference]
  23. Umegaki K: “Development of the innovative proton beam therapy system – Implementation of proton beam therapy at Hokkaido University and future development”, Kaderu Sapporo 2.7, 2014 Annual Meeting on Radioisotope and Radiation Research, 2014.10.31 [Japanese conference]
  24. Masayori Ishikawa, Toshiyuki Minemura, Hidenobu Tachibana, Yasumasa Nishimura, Teiji Nishio, Yuichiro Narita, Naoki Tohyama, Kazuhiko Tsuchiya, Ryusuke Suzuki, Satoshi Ishikura, “Feasibility study on a new film analysis method applying for IMRT credentialing in multi-institutional clinical trials,” 14th Asia-Oceania Congress of Medical Physics, (2014.10.23-25) Ho Chi Minh City (Invited) [International conference]
  25. Shimizu S: “The world first spot scanning proton beam therapy with IGRT”, Sapporo Convention Center, Educational Lecture at the 42nd Autumn Assembly of Japanese Society of Radiological Technology, 2014.10.11 [Japanese conference]
  26. Shimizu S, Shirato H, Umegaki K, Hokin K: “Spot Scanning Proton beam therapy –State-of-the-art technology.”, Yuzhno-Sakhalinsk (Russia), Sakhalin Cancer Conference.”, 2014.10.1-3 [International conference]
Other presentations
  1. Wu PH, Onodera Y, Ichikawa Y, Watanabe Y, Wei Q, Hashimoto T, Shirato H, Nam JM: “RGD-conjugated gold nanoparticles in radiotherapy decreases the invasion activity in breast cancer cells.”, Sapporo, The 3rd GI-CoRE Medical Science and Engineering Symposium. Radiation Oncology, Biology&IVR, 2016.3.3-4 [International conference]
  2. Wu PH, Onodera Y, Ichikawa Y, Watanabe Y, Qian W, Hashimoto T, Shirato H, Nam JM: “Effects of RGD peptide conjugated gold nanoparticles in Breast Cancer Cells with ionization radiation.”, San Diego, ASCB Annual meeting, San Diego (U.S.A.), 2015.12.12-16 [International conference]
  3. Shimizu S, Katoh N, Nishioka K, Hashimoto T, Inoue T, Matsuura T, Takao S, Matsuzaki Y,Fujii Y, Tamura M, Onimaru R, Umegaki K, Shirato H: “Initial clinical experience of spot-scanning proton beam therapy using real-time-image gated proton-beam therapy system.”, Dresden (Germany), 4D Treatment Planning Workshop 2015, 2015.11.26-27 [International conference]
  4. Matsuura T, Takao S, Matsuzaki Y, Fujii Y, Fujii T, Miyamoto N, Katoh N, Shimizu S, Shirato H, Umegaki K: “Treatment of superficial liver tumors with spot-scanning proton therapy using real-time gating system-comparison between range compensation devices.”, OncoRay, Dresden (Germany), 7th International 4D Treatment Planning Workshop, 2015.11.26-27 [International conference]
  5. Shimizu S, Katoh N, Takao S, Matsuura T, Miyamoto N, Hashimoto T, Nishioka K, Yoshimura T, Matsuzaki Y, Kinoshita R, Nishikawa Y, Onimaru R, Umegaki K, Shirato H: “Treatment of respiratory moving liver tumor using gated spot scanning proton beam therapy system with real-time tumor-tracking function.”, San Antonio (U.S.A.), ASTRO 57th Annual meeting, 2015.10.18-21 [International conference]
  6. Umegaki K, Matsuura T, Takao S, Matsuzaki Y, Yamada T, Fujii Y, Miyamoto N, Shimizu S, Shirato H: “Startup experience of the new proton beam therapy with gated spot scanning and real-time tumor-tracking.”, Anaheim (U.S.A.), 57th AAPM Annual Meeting, 2015.7.16 [International conference]
  7. Matsuura T, Fujii Y, Takao S, Yamada T, Matsuzaki Y, Miyamoto N, Takayanagi T, Fujitaka S, Shimizu S, Shirato H, Umegaki K: “Development of An Applicator for Treating Shallow and Moving Tumors with Respiratory-Gated Spot-Scanning Proton Therapy Using Real-Time Image Guidance”, Anaheim (U.S.A.), 57th AAPM Annual Meeting, 2015.7.12-16 [International conference]
  8. Tha KK, Katscher U, Stehning C, Yamaguchi S, Terasaka S, Shirato H: “Electrical Conductivity Characteristics of Glioma and Potential Usefulness of Noninvasive Electrical Conductivity Measurement in Evaluation of Glioma.”, Chicago (U.S.A.), 101st Annual Meeting of RSNA, 2015.11.29 [International conference]
  9. Nam JM, Onodera Y, Sabe H, Shirato H: “Analysis of molecular mechanism involved in maintenance of 3-dimensional structure on radiation treated mammary epithelial cells.”, Nagoya, The 74th Annual Meeting of the Japanese Cancer Association, 2015.10.8-10[Japanese conference]
  10. Tha KK, Katscher U, Stehning C, Yamaguchi S, Terasaka S, Yamamoto T, Kudo K, Shirato H: “The Electrical Conductivity Characteristics of Glioma and Potential Usefulness of Noninvasive Electrical Conductivity Measurement in Evaluation of Glioma.”, Tokyo, JSMRM 43rd Annual Meeting, 2015.9.10-12 [Japanese conference]
  11. Wang J, Kato F, Yamashita H, Malkov S, Shepherd J, Kudo K, Shirato H: “Volumetric Breast Density of Japanese Women Using Adaptive Pattern Recognition-Based Calibrations.”, San Francisco (U.S.A.), 7th International Workshop on Breast Densitometry and Cancer Risk Assessment, 2015.6.10-12 [International conference]
  12. Kudo K, Uwano I, Hirai T, Nakamura H, Fujima N, Yamashita F, Goodwin J, Higuchi S, Sasaki M: “Diagnostic Performance of Dynamic Susceptibility Contrast Perfusion in Glioma Grading: Comparison of Cerebral Blood Volume among Different Analysis Software.”, Tronto (Canada), 23rd ISMRM, 2015.6.1-5 [International conference]
  13. Tha KK, Ulrich K, Stehning C, Yamaguchi S, Terasaka S, Sugimori H, Yamamoto T, Fujima N, Kudo K, Suzuki Y, van Cauteren M, Shirato H: “Electrical Conductivity Characteristics of Meningiomas: Noninvasive Assessment using Electric Properties Tomography.”, Toronto (Canada), ISMRM 23rd Annual Meeting & Exhibition, 2015.5.30-6.5 [International conference]
  14. Kudo K: “Perfusion MRI for the Diagnosis of Brain Tumors.”, Tokyo, Advanced Neuroimaging Workshop, 2015.5.23 [Japanese conference]
  15. Matsuura T, Fujii Y, Takao S, Matsuzaki Y, Yamada T, Matsuo Y, Fujitaka S, Takayanagi T, Umegaki K, Shirato H: “Development of an range compensator for spot-scanning proton therapy using real-time gating system.”, Yokohama, 109th Japan Society of Medical Physics, 2015.4.16-19 [Japanese conference]
  16. Kudo K: “Perfusion MRI for the Diagnosis of Brain Tumors.”, Seoul (South Korea), KSMRM, 2015.3.27-28[International conference]
  17. Tha KK, Ulrich K, Stehning C, Yamaguchi S, Terasaka S, Sugimori H, Yamamoto T, Fujima N, Kudo K, Suzuki Y, van Cauteren M, Shirato H: “Electrical Conductivity Characteristics of Meningiomas: Noninvasive Assessment using Electric Properties Tomography.”, Nagoya, Japan Society of Neuroradiology 44th Annual Meeting, 2015.3.6-7 [Japanese conference]
  18. Tha KK, Katscher U, Yamaguchi S, Terasaka S, Stehningn C, Fujima N, Kudo K, Shirato H: “Electrical conductivity characteristics of meningiomas: the results of a noninvasive assessment.”, Nagoya, Japan Society of Neuroradiology 44th Annual Meeting, 2015.3.6 [Japanese conference]
  19. Wang J, Kato F, Kudo K, Yamashita H, Shirato H: “Heterogeneity of Background Parenchymal Enhancement on MRI Strongly Predictive of Breast Cancer Molecular Subtypes.”, Chicago (U.S.A.), 100th Annual Meeting of RSNA , 2014.11.30-12.5 [International conference]
  20. Yasuda K, Tsuchiya K, Onimaru R, Harada Y, Harada K, Nishikawa Y, Kinoshita R, Tsuji S, Horita K, Suzuki R, Shirato H: “Effects of narrow CTV-PTV margin on variability of radiation dose prescription in cases that CTV was close to OAR.”, Yokohama, The 27th annual meeting of Japanese Society for Radiation Oncology (JASTRO), 2014.11.13 [Japanese conference]
  21. Nam JM, Onodera Y, Sabe H, Shirato H: “Analysis of molecular mechanism involved in invasiveness of radiation treated breast cancer cells.”, Yokohama, The 73th Annual Meeting of the Japanese Cancer Association, 2014.9.25-27 [Japanese conference]
  22. Kudo K: “Oxygen Extraction Fraction (OEF) Measurement using Quantitative Susceptibility Mapping (QSM).”, Kobe, 15th AOCR, 2014.9.24 [International conference]
  23. Shimizu S, Takao S, Matsuura T, Miyamoto N, Baba R, Umekawa T, Matsuda K, Sasaki T, Nagamine Y, Umegaki K, Shirato H: “Realization of the Cone Beam CT by FPDs That Mounted on the Spot-Scanning Dedicated Proton Beam Gantry.”, San Francisco (U.S.A.), ASTRO 56th Annual meeting, 2014.9.14-17 [International conference]
  24. Katoh N, Onishi H, Matsushita H, Nomiya T, Nakata K, Shirato H: “Japanese Multi-institutional Study of Stereotactic Body Radiation Therapy For Renal and Adrenal Tumors.”, San Francisco (U.S.A.), ASTRO 56th Annual meeting, 2014.9.14-17[International conference]
  25. Sutherland K, Kanehira T, Matsuura T, Umegaki K and Shirato H, “Geant4 Simulations of Spot-Scanned Proton Beam Treatment Plans”, Austin, AAPM 56th Annual Meeting & Exhibition, July 20-24 2014.7.20-14 [International conference]
  26. Wang J, Kato F, Kudo K, Yamashita H, Shirato H: “Predicting Triple-Negative Breast Cancer and Axillary Lymph Node Metastasis using Diagnostic MRI.”, Gifu, IWDM 2014, 2014.6.29-7.2 [International conference]
  27. Tha KK, Stehning C, Suzuki Y, Katscher U, Keupp J, Kazumata K, Terasaka S, Cauteren MV, Kudo K, Shirato H: “Noninvasive Evaluation of Electrical Conductivity of the Normal Brain and Brain Tumors.” Milan (Italy), 22nd ISMRM, 2014.5.12-16[International conference]
  28. Tha KK, Stehning C, Suzuki Y, Ulrich K, Jochen K, Kazumata K, Terasaka S, van Cauteren M, Kudo K, Shirato H: “Noninvasive evaluation of electrical conductivity of the normal brain and brain tumors.” Milan (Italy), The joint annual meeting ISMRM-ESMRMB, 2014.5.10-16 [International conference]
  29. Kudo K, Liu T, Goodwin J, Uwano I, Yamashita F, Higuchi S, Fujima N, Wang Y, Ogasawara K, Ogawa A, Sasaki M: “Oxygen Extraction Fraction Measurement using Quantitative Susceptibility Mapping in Patients with Chronic Cerebral Ischemia: Comparison with Positron Emission Tomography.”, Milan (Italy), ISMRM, 2014.5.12-16 [International conference]
  30. Inoue T, Katoh N, Shimizu S, Suzuki R, Sasaki T, Fukusima H, Komatsu Y, Shirato H. Chemoradiation therapy using intensity-modulated radiation therapy for locally advanced esophageal carcinoma.”, Yokohama, The 73rd Annual Meeting of the Japan Radiological Society. 2014.4.10-13 [Japanese conference]
Awards
  1. Shirato H: “Development and Clinical Research of a highly precise photon and particle beam therapy using stereotactic irradiation and real-time tumor tracking technologies” (The 2014 Hokkaido Science and Engineering Award), 2015.2.20
  2. Shirato H: Hokkaido University President’s Award for Research Excellence for AY2014 (Excellent Research Award), 2015.3.11
  3. Umegaki K: “Development and practical application of a Proton Beam Therapy System with 4-D Real-time Tumor Tracking”, (The 13th Merit Award for Industry-Academia-government Collaboration, the Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology), 2015.8.28
  4. Yasuda K: “[18F] fluoromisonidazole and a new PET system with semiconductor detectors and a depth of interaction system for intensity modulated radiation therapy for nasopharyngeal cancer.”, (The Umegaki award, 20th Japanese Society for Radiation Oncology (JASTRO)), 2014.12.12